{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:51:14Z","timestamp":1789527074521,"version":"build-2803163510"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.eururo.2024.01.004","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T20:52:55Z","timestamp":1706215975000},"page":"317-319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["The Elusive Horizon: Biomarkers in Urothelial Carcinoma"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4599-1923","authenticated-orcid":false,"given":"Joshua A.","family":"Linscott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua J.","family":"Meeks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Dyrskj\u00f8t","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1274-7200","authenticated-orcid":false,"given":"Roger","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2024.01.004_b0005","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00345-012-0935-9","article-title":"Urinary BTA: indicator of bladder cancer or of hematuria","volume":"30","author":"Miyake","year":"2012","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2024.01.004_b0010","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00432-016-2310-5","article-title":"Comparison of different concepts for interpretation of chromosomal aberrations in urothelial cells detected by fluorescence in situ hybridization","volume":"143","author":"Mischinger","year":"2017","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.eururo.2024.01.004_b0015","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41585-023-00773-8","article-title":"Urine biomarkers in bladder cancer \u2014 current status and future perspectives","volume":"20","author":"Maas","year":"2023","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.eururo.2024.01.004_b0020","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ccell.2016.05.004","article-title":"Comprehensive transcriptional analysis of early-stage urothelial carcinoma","volume":"30","author":"Hedegaard","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.eururo.2024.01.004_b0025","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","article-title":"Comprehensive molecular characterization of muscle-invasive bladder cancer","volume":"171","author":"Robertson","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.eururo.2024.01.004_b0030","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.euo.2021.10.003","article-title":"Diagnostic accuracy of novel urinary biomarker tests in non\u2013muscle-invasive bladder cancer: a systematic review and network meta-analysis","volume":"4","author":"Laukhtina","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.eururo.2024.01.004_b0035","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eururo.2023.07.014","article-title":"Field cancerization is associated with tumor development, T-cell exhaustion, and clinical outcomes in bladder cancer","volume":"85","author":"Strandgaard","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2024.01.004_b0040","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1158\/2159-8290.CD-18-0825","article-title":"Detection and surveillance of bladder cancer using urine tumor DNA","volume":"9","author":"Dudley","year":"2019","journal-title":"Cancer Discov"},{"issue":"6 Suppl","key":"10.1016\/j.eururo.2024.01.004_b0045","doi-asserted-by":"crossref","first-page":"LBA445","DOI":"10.1200\/JCO.2023.41.6_suppl.LBA445","article-title":"Cell-free urinary tumor DNA to detect minimal residual disease prior to repeat-transurethral resection of bladder tumor in non\u2013muscle-invasive bladder cancer: a prospective study","volume":"41","author":"Rose","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2024.01.004_b0050","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.euo.2018.04.010","article-title":"Optimal Trial design for studying urinary markers in bladder cancer: a collaborative review","volume":"1","author":"Lotan","year":"2018","journal-title":"Eur Urol Oncol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030228382400006X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030228382400006X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T13:58:07Z","timestamp":1738072687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030228382400006X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S030228382400006X"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2024.01.004","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Elusive Horizon: Biomarkers in Urothelial Carcinoma","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2024.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}